Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Cleveland Biolabs, Inc.
(NQ:
CBLI
)
1.660
USD
+0.020 (+1.22%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Cleveland Biolabs, Inc.
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Cleveland BioLabs Doses First Healthy Volunteer in Initial Safety Study for Protectan CBLB502
October 15, 2008
from
Marketwired News Releases
Zacks Analyst Blog Highlights: Philip Morris International, Inc., Altria Group, Inc., Cleveland BioLabs, Inc., Scientific Games Corp. and FactSet Research Systems Inc.
September 30, 2008
from
Business Wire News Releases
Cleveland BioLabs to Present at Maxim Group Growth Conference
September 29, 2008
from
Marketwired News Releases
Cleveland BioLabs to Present Protectan CBLB502 at 2008 BARDA Day
September 23, 2008
Recently Awarded $13.3 Million BARDA Development Contract for Protectan CBLB502
Read More
from
Marketwired News Releases
Biomedical Advanced Research and Development Authority of the Department of Health and Human Services (BARDA) Awards Cleveland BioLabs Contract to Develop Protectan CBLB502
September 16, 2008
from
Marketwired News Releases
National Institute of Allergy and Infectious Diseases Awards Cleveland BioLabs Grant for Protectan CBLB502 Research in Mitigation of Radiation Damage
September 12, 2008
Supports Investigation of Ability to Reduce Occurrence and Severity of Thrombocytopenia and Improve Recovery Time
Read More
from
Marketwired News Releases
Cleveland BioLabs and Cleveland Clinic Demonstrate Accelerated Recovery of Limb Function With Protectan CBLB502 in Tourniquet Injury Model
August 13, 2008
Potential Application for Battlefield and Natural Disaster Conditions
Read More
from
Marketwired News Releases
Cleveland BioLabs Receives Notice of Allowance From FDA to Commence Clinical Testing With Protectan CBLB502
August 07, 2008
from
Marketwired News Releases
Zacks Bull and Bear of the Day Highlights: Logitech International, Freddie Mac, Stryker, Cleveland BioLabs and Polycom
July 21, 2008
from
Business Wire News Releases
Cleveland BioLabs Granted First Patent for Protectan CBLB502
July 08, 2008
from
Marketwired News Releases
Dongfang Electric's First 300-Megawatt CFB Boiler Begins Operation
June 25, 2008
BEIJING--June 25, 2008--Researched by Industrial Info Resources (Sugar Land, Texas)--The circulating fluidized-bed (CFB) boiler in Phase II of the Heshuyuan Power Plant project is the first...
Read More
from
IIR Industry News Alerts
Cleveland BioLabs Featured in Note From CEO of The Robins Group, LLC
May 29, 2008
from
Marketwired News Releases
Cleveland BioLabs to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
May 14, 2008
from
Marketwired News Releases
Cleveland BioLabs Completes Recruitment for Phase II Hormone-Refractory Prostate Cancer Trial
May 07, 2008
from
Marketwired News Releases
Buyins.net Initiates Coverage on Cleveland BioLabs With SqueezeTrigger Price of $7.41
May 07, 2008
from
Marketwired News Releases
Cleveland BioLabs Featured in "Gene Marcial's 7 Commandments of Stock Investing"
May 05, 2008
from
Marketwired News Releases
Cleveland BioLabs Management Reviews 2008 Highlights and Milestones at Annual Meeting
April 29, 2008
from
Marketwired News Releases
Market Pulse Announces Its Hot Stock Alerts for Tuesday, April 15, 2008: NCEN, AAPL, BEXP, CBLI
April 15, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.
Read More
from
Marketwired News Releases
Cleveland BioLabs to Highlight Recent Achievements and Provide Update on Development Strategy on April 17 Conference Call
April 14, 2008
from
Marketwired News Releases
Closing Bell Report
April 11, 2008
The markets skidded to close sharply lower after GE reported disappointing first quarter results that fell short of estimates and forecast second quarter earnings below expectations. The Dow plummeted...
Read More
category
Market News
from
MarketMinute.com Market Updates
Unusual 11 Mid-Day Movers 4/11: SGN, IFC, PTRY, PDLI Higher; FRNT, PWER, INTV, GE Lower
April 11, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3539028 for the full story.
Read More
from
StreetInsider.com News Articles
WBB Securities Upgrades Cleveland BioLabs to Strong Buy and Reiterates $13 Price Target
April 11, 2008
from
Marketwired News Releases
Cleveland Biolabs (CBLI) CBLB502 Drug May Protect Soliders from Radiation Sickness -Bloomberg
April 10, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3536359 for the full story.
Read More
from
StreetInsider.com News Articles
Science Magazine Publishes Cleveland BioLabs Breakthrough Paper on Protectan CBLB502's Radioprotective Activity
April 10, 2008
Department of Defense Recently Awarded $8.9 Million Development Contract for Protectan CBLB502
Read More
from
Marketwired News Releases
Cleveland BioLabs to Submit Protectan CBLB502 for BARDA BAA for Development of Therapies to Protect Civilian Population From Radiation Exposure
April 09, 2008
Expands Market Opportunity Beyond Recent Department of Defense Development Contract for $8.9 Million and Potential Military Purchase
Read More
from
Marketwired News Releases
Cleveland BioLabs (CBLI) Awarded DoD Contract To Develop Protectan CBLB502
April 03, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3515777 for the full story.
Read More
from
StreetInsider.com News Articles
Department of Defense Awards Cleveland BioLabs Contract to Develop Protectan CBLB502
April 03, 2008
from
Marketwired News Releases
Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Mitigation Of Hematopoietic Damage at 48 Hours Post-Exposure to 6.5 Gy of Radiation
March 31, 2008
Highlights Broad Agency Announcement From BARDA for Development of Therapies for Acute Exposure to Ionizing Radiation
Read More
from
Marketwired News Releases
Cleveland BioLabs CEO to Present at 3rd Annual Stem Cell Summit in New York City
February 20, 2008
from
Marketwired News Releases
Cleveland BioLabs (CBLI) Announces Positive CBLB502 Results
February 19, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3378525 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here